Melatonin vs Resveratrol for Anti-Inflammation: Which Is Better?

Melatonin vs Resveratrol for Anti-Inflammation: Which Is Better?

Overview

Inflammation is at the root of numerous chronic diseases, from cardiovascular disease and diabetes to autoimmune conditions and neurodegenerative disorders. As a result, anti-inflammatory compounds have become increasingly popular among those seeking to manage inflammatory markers and support long-term health. Two supplements that have gained significant attention for their anti-inflammatory properties are melatonin and resveratrol.

While melatonin is best known for regulating sleep and circadian rhythms, emerging research reveals potent anti-inflammatory and antioxidant effects beyond sleep support. Resveratrol, a polyphenol found in red grapes and berries, has long been studied for its broad health benefits, including robust anti-inflammatory activity. Both compounds demonstrate Tier 4 evidence—the highest tier—for reducing inflammatory markers in human studies, making them worthy of direct comparison.

This article examines the anti-inflammatory evidence for both compounds to help you understand their mechanisms, efficacy, dosing, safety, and cost, enabling an informed decision about which might be better suited to your needs.

Quick Comparison Table: Anti-Inflammation

Resveratrol for Anti-Inflammation

Mechanism of Anti-Inflammatory Action

Resveratrol exerts anti-inflammatory effects through multiple complementary pathways. Its primary mechanism involves SIRT1 activation, a NAD+-dependent deacetylase that modulates cellular stress responses and reduces pro-inflammatory gene expression. Additionally, resveratrol inhibits NF-κB signaling, a master regulator of inflammation that controls the production of pro-inflammatory cytokines like TNF-α and IL-6. The compound also acts as a potent scavenger of reactive oxygen species through its phenolic hydroxyl groups, reducing oxidative stress that drives inflammation. Resveratrol further inhibits COX-1 and COX-2 enzymes, similar to non-steroidal anti-inflammatory drugs, providing an additional anti-inflammatory pathway.

Evidence for Anti-Inflammatory Efficacy

The evidence supporting resveratrol's anti-inflammatory properties is substantial. Meta-analyses spanning 17 randomized controlled trials with 736 participants documented TNF-α reductions of -0.44 ng/mL across mixed populations. In type 2 diabetes patients specifically, TNF-α reduction reached -1.25 ng/mL (p<0.001), indicating particularly robust effects in this population.

For C-reactive protein (CRP), a systemic marker of inflammation, resveratrol demonstrated a standardized mean difference of -1.40 (95% CI -2.60 to -0.21, p=0.02) in type 2 diabetes patients across 6 randomized trials involving 533 participants. In obesity-focused meta-analyses, the effect size was -0.390 (p<0.001) across 81 unique trials, confirming consistent benefits.

Interleukin-6 (IL-6) reduction in type 2 diabetes patients reached -1.99 pg/mL (95% CI -3.29 to -0.69, p<0.001) in a 110-participant randomized trial, though broader obesity meta-analyses did not consistently demonstrate significant IL-6 reduction.

A particularly informative study in 110 type 2 diabetic patients over 24 weeks found that resveratrol supplementation significantly reduced multiple inflammatory markers including TNF-α, IL-6, and high-sensitivity CRP while also reducing oxidative stress biomarkers—all without measuring muscle mass outcomes, suggesting resveratrol's anti-inflammatory effects are independent of muscle-building mechanisms.

Consistency Across Populations

An important caveat to resveratrol's anti-inflammatory efficacy is that benefits appear most robust in specific disease populations—particularly those with type 2 diabetes, obesity, and autoimmune conditions like multiple sclerosis. Rather than functioning as a universal anti-inflammatory agent, resveratrol appears to be most effective when addressing inflammation in metabolic or autoimmune disease contexts.

Melatonin for Anti-Inflammation

Mechanism of Anti-Inflammatory Action

While melatonin is primarily known for its circadian rhythm regulation via MT1 and MT2 receptor agonism, its anti-inflammatory mechanisms are distinct from resveratrol's. Melatonin acts as a direct free radical scavenger, neutralizing reactive oxygen species independent of receptor binding. It also upregulates endogenous antioxidant enzymes including superoxide dismutase (SOD) and glutathione peroxidase, enhancing the body's intrinsic antioxidant defenses. These mechanisms converge to reduce systemic inflammation by limiting oxidative stress—a primary driver of inflammatory cascade activation.

Evidence for Anti-Inflammatory Efficacy

Melatonin's anti-inflammatory evidence is similarly robust to resveratrol's. A comprehensive meta-analysis of 63 randomized controlled trials found that melatonin reduced:

• C-reactive protein by -0.59 mg/L
• TNF-α by -1.61 pg/mL
• IL-6 by -6.43 pg/mL

An additional meta-analysis of 13 studies involving 749 participants documented even larger reductions in TNF-α (-2.24 pg/mL, 95% CI -3.45 to -1.03, p<0.001) and IL-6 (-30.25 pg/mL, 95% CI -41.45 to -19.06, p<0.001), suggesting that in certain populations or studies, melatonin's IL-6-lowering effect may be particularly pronounced.

In diabetic chronic kidney disease patients specifically, a randomized trial involving 41 participants found that 5 mg melatonin administered twice daily for 10 weeks decreased high-sensitivity CRP, malondialdehyde (oxidative stress), and total oxidative status—all markers of systemic inflammation and oxidative stress.

Consistent Efficacy Across Disease States

Like resveratrol, melatonin's anti-inflammatory benefits are primarily documented in disease-specific populations including diabetes, metabolic syndrome, and multiple sclerosis. However, the magnitude of IL-6 reduction observed in some melatonin trials (up to -30.25 pg/mL) is notably larger than resveratrol's documented IL-6 reductions, suggesting differential effects on this particular inflammatory cytokine.

Head-to-Head: Anti-Inflammation Evidence Comparison

Both resveratrol and melatonin carry Tier 4 evidence for anti-inflammatory efficacy, the highest classification available. This designation indicates that both compounds demonstrate strong evidence for reducing inflammatory markers in humans across multiple randomized controlled trials and meta-analyses with consistent effect sizes.

TNF-α Reduction

Resveratrol: -0.44 to -1.25 ng/mL (depending on population; strongest in T2DM)
Melatonin: -1.61 to -2.24 pg/mL (depending on study)

Note: These measurements use different units (ng/mL vs. pg/mL), making direct numerical comparison challenging. However, both achieve statistically significant and clinically relevant reductions across multiple studies.

CRP Reduction

Resveratrol: SMD -1.40 in T2DM; -0.390 in obesity
Melatonin: -0.59 mg/L across mixed populations

Melatonin demonstrates more consistent CRP reduction across diverse populations, while resveratrol shows stronger effects specifically in diabetes.

IL-6 Reduction

Resveratrol: -1.99 pg/mL in T2DM (no consistent effect in broader obesity populations)
Melatonin: -6.43 to -30.25 pg/mL (depending on study population)

Melatonin shows substantially larger IL-6 reductions, particularly in certain disease contexts. This may represent a key advantage for those specifically concerned with elevated IL-6.

Mechanistic Overlap and Divergence

Both compounds reduce inflammation, but through partially distinct mechanisms. Resveratrol's SIRT1 activation and NF-κB inhibition represent more targeted metabolic signaling, while melatonin's direct free radical scavenging and antioxidant enzyme upregulation may offer broader antioxidant support. Theoretically, combining both could yield additive anti-inflammatory benefits, though direct combination studies are limited.

Dosing Comparison

Resveratrol Dosing for Anti-Inflammation

The meta-analytic evidence for anti-inflammatory efficacy suggests that benefits emerge at doses ≥400-500 mg daily for durations of ≥12 weeks. Standard supplemental doses typically range from 250-500 mg once daily, though some studies used up to 1000 mg daily—beyond which gastrointestinal side effects become more common.

For practical anti-inflammatory purposes, 500 mg once daily represents a reasonable middle ground based on the evidence.

Melatonin Dosing for Anti-Inflammation

Melatonin's anti-inflammatory benefits have been documented at doses ranging from 3-20 mg daily, with most anti-inflammatory research conducted at 5-10 mg daily. This is substantially lower than resveratrol on a per-dose basis. A double-blind trial in diabetic chronic kidney disease patients used 5 mg twice daily (10 mg total) with demonstrated anti-inflammatory benefits.

For anti-inflammatory purposes specifically, 5-10 mg daily appears reasonable based on the available evidence.

Dosing Practical Comparison

Resveratrol requires a higher absolute dose (250-500 mg) but is taken once daily, favoring adherence. Melatonin requires a lower absolute dose (5-10 mg) but has traditionally been associated with evening dosing (for sleep benefits), which may be less convenient if anti-inflammation is the sole goal. However, some evidence suggests melatonin's anti-inflammatory benefits occur independent of sleep effects, potentially allowing flexible timing.

Safety Comparison

Resveratrol Safety

Resveratrol maintains a generally favorable safety profile at doses up to 500 mg daily, with most adverse effects being gastrointestinal and dose-dependent. Common side effects include nausea, bloating, and loose stools, particularly at doses above 1000 mg daily. Some users report mild headaches, especially at higher doses.

At high doses (1 g+/day), mixed signals have emerged in clinical trials including potential pro-oxidant effects (paradoxically increasing oxidative stress) and interference with exercise adaptation, suggesting that more is not necessarily better. Additionally, resveratrol's phytoestrogenic activity (mild estrogenic effects) warrants caution in individuals with hormone-sensitive conditions, particularly at sustained high doses.

Summary: Safe at recommended doses; monitor for GI effects and avoid very high doses.

Melatonin Safety

Melatonin has an excellent short-term safety profile and is one of the most widely used sleep supplements globally. Common side effects include morning grogginess (particularly at doses >3 mg), dizziness, headache, nausea, and vivid dreams—all generally mild.

However, long-term effects of pharmacological doses remain understudied, and melatonin is classified as a prescription medication in several countries (UK, Germany, Australia) for doses above 2 mg, indicating regulatory caution regarding long-term use. Use warrants caution in children, pregnant or breastfeeding individuals, and those with autoimmune conditions, as melatonin can modulate immune function—potentially problematic in those with dysregulated immunity.

Summary: Excellent short-term safety; long-term effects less studied; immune modulation warrants caution in autoimmune disease.

Cost Comparison

• Resveratrol: $10-$45 per month
• Melatonin: $4-$20 per month

Melatonin is substantially less expensive, typically costing one-third to one-half as much as resveratrol. For those prioritizing cost-effectiveness, melatonin represents a significant financial advantage. However, both compounds remain inexpensive relative to many pharmaceutical and nutraceutical alternatives.

Which Should You Choose for Anti-Inflammation?

Choose Resveratrol if:

• You have type 2 diabetes or obesity with documented inflammation, as evidence is most robust in these populations
• You seek broader metabolic and cardiovascular benefits beyond anti-inflammation (improved endothelial function, glucose control)
• You tolerate oral supplements well and prefer once-daily dosing
• You want to avoid potential immune modulation (relevant for autoimmune conditions)

Choose Melatonin if:

• You have elevated IL-6 specifically, given melatonin's pronounced effects on this cytokine
• You also suffer from sleep disruption or circadian rhythm disorders, enabling dual benefit
• Cost is a primary concern, as melatonin is significantly cheaper
• You prefer lower absolute doses (5-10 mg vs. 250-500 mg)
• You have concerns about hormone sensitivity from phytoestrogens

Consider Both if:

• You have access to both and tolerate them well
• Your inflammation is particularly resistant to single-agent therapy
• You want to address multiple inflammatory pathways simultaneously
• You lack contraindications (autoimmune disease for melatonin; hormone-sensitive conditions for resveratrol at high doses)

The Bottom Line

Both resveratrol and melatonin carry Tier 4 evidence for anti-inflammatory efficacy, meaning both compounds demonstrate strong, consistent effects on inflammatory markers in human randomized controlled trials. Neither holds a clear absolute advantage; rather, they offer different value propositions.

Resveratrol excels for those with metabolic disease (diabetes, obesity) who want broader cardiometabolic benefits alongside anti-inflammation. Melatonin excels for those seeking cost-effective anti-inflammation, particularly those with elevated IL-6 or concurrent sleep disruption.

The choice ultimately depends on your specific health context, budget, tolerance, and whether additional benefits beyond anti-inflammation matter to you. For maximum impact, some individuals may benefit from both—though this should be discussed with a healthcare provider, particularly if you have autoimmune disease, hormone-sensitive conditions, or take medications that may interact with either compound.

Disclaimer

This article is educational content only and should not be construed as medical advice. The information presented reflects current scientific evidence but does not replace professional medical counsel. Before beginning any supplementation regimen, particularly if you have existing health conditions, take medications, are pregnant or breastfeeding, or have autoimmune disease, consult with a qualified healthcare provider to determine what is appropriate for your individual circumstances.